glp 1 proteinuria Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis Kidney function loss and albuminuria

Apparently, food companies have no needor timeto find out

Invega Sustenna/Xeplion/Invega Trinza/Trevicta (paliperidone) Disease area(s): Psychiatry Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $4.22 billion Why it sold so well: In 2024, J&Js long-acting antipsychotic portfolio including Invega Sustenna, Xeplion, Invega Trinza and Trevicta registered global sales of $4.22 billion, reflecting a 2.6% year-over-year increase

Entre las razones est que su uso masivo para adelgazar provoc escasez de estos productos para los pacientes diabticos, al tiempo que surgi un debate tico sobre su utilizacin con fines estticos y su elevado precio para los sistemas sanitarios nacionales

I cant wait to see what comes next